GRI Bio GRI
NASDAQ GRI
$1.47 +0.01 (+0.68%)
At close: Oct 21, 2026 · 4:00 PM EDT

GRI Bio (GRI) Notes Payables (2020 - 2022)

Updated

GRI Bio's Notes Payables was $602,000 in Q4 2022.

Analysis

GRI Bio (GRI) Notes Payables (2020 - 2022) Analysis & Trends

  • In earlier years, Notes Payables was $47,000 in FY2020.
  • The Q4 2022 figure marks the lowest quarterly Notes Payables since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 GRI Bio 2.65 Mn -31.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 602,000.00
Dec 31, 2020 47,000.00
API Access

GRI Bio Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=GRI&period=max&api_key=YOUR_API_KEY